V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190006965 | 190001700 | null | null | null | null | 2016-04-03 | Vemurafenib | null | null | CISPLATIN + RT | 100431752 |
| 190006969 | 190001702 | 1.74 | 69.95 | Palliative (P) | 2016-08-18 | 2016-08-18 | null | N | N | EPIRUBICIN | 100730196 |
| 190006971 | 190001703 | null | null | null | null | 2016-07-30 | GEMCITABINE + NAB PACLITAXEL | null | null | CAPECITABINE + TEMOZOLOMIDE | 101199807 |
| 190006973 | 190001704 | 1.65 | 62 | Palliative (P) | 2018-10-28 | 2018-11-05 | EW EuroEwing 2012 Arm A VIDE | 02 | Y | GEMCITABINE + NAB-PACLITAXEL | 101679012 |
| 190006979 | 190001705 | null | null | null | null | 2017-08-06 | CISPLATIN + RT | null | null | GEMCARBO | 101171123 |
| 190006981 | 190001706 | 1.78 | 74.1 | null | null | 2016-06-11 | CARBOPLATIN + FLUOROURACIL | null | null | CISPLATIN + FLUOROURACIL + RT | 101088493 |
| 190006986 | 190001708 | 1.66 | 97 | Curative (C) | 2018-04-25 | 2018-04-27 | OST Euramos 1 Closed Trial - Ai | 02 | N | LANREOTIDE | 101677995 |
| 190006988 | 190001709 | null | null | null | null | 2018-12-20 | BENDAMUSTINE + THALIDOMIDE | null | null | DOCETAXEL | 101502540 |
| 190007007 | 190001716 | null | 84.8 | Palliative (P) | 2016-12-15 | 2016-12-19 | GemCarbo Days 1+8 | N | N | GEMCITABINE | 100173845 |
| 190007010 | 190001718 | 1.69 | 91 | Curative (C) | 2020-01-26 | 2020-01-30 | Cisplatin + Docetaxel | 02 | N | FCARBOST | 100812199 |
| 190007022 | 190001721 | null | null | null | null | 2017-05-03 | EW Rel rEECur Irinotecan/Temozolomide | null | null | ECX | 100001566 |
| 190007027 | 190001723 | 1.5 | 78.6 | Palliative (P) | 2018-04-08 | 2018-04-26 | Sunitinib | N | N | CARBOPLATIN + VINORELBINE | 101246850 |
| 190007041 | 190001726 | null | null | null | null | 2017-02-20 | EURAMOS TRIAL | null | null | CISPLATIN + RT | 100298617 |
| 190007042 | 190001727 | 1.66 | 90.8 | Curative (C) | 2017-03-21 | 2017-03-29 | EW EuroEwing 2012 Arm B VDC | 02 | null | ECX | 101052765 |
| 190007044 | 190001729 | 1.73 | 16.4 | Neo-adjuvant (N) | 2018-11-22 | 2018-11-22 | Gemcitabine + Capecitabine | N | N | EURO-EWING | 100642637 |
| 190007055 | 190001733 | null | null | null | null | 2017-09-22 | Cisplatin | null | null | CISPLATIN | 101050437 |
| 190007058 | 190001734 | 1.65 | 19.2 | Palliative (P) | 2018-10-24 | 2018-10-26 | EOX | 02 | N | INTERFERON ALFA | 100599504 |
| 190007066 | 190001736 | 1.75 | 19.2 | Neo-adjuvant (N) | 2016-08-11 | 2016-08-11 | CAPECITABINE + CARBOPLATIN + Cetuximab | 02 | N | CISPLATIN + RT | 101327755 |
| 190007071 | 190001739 | null | null | null | null | 2017-12-11 | CISPLATIN + ETOPOSIDE | null | null | GEMCITABINE | 100010980 |
| 190007073 | 190001740 | null | null | null | null | 2016-02-03 | CARBOPLATIN + ETOPOSIDE | null | null | CARBOPLATIN + ETOPOSIDE | 100621110 |
| 190007083 | 190001744 | null | null | null | null | 2017-08-11 | EURAMOS TRIAL | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100629520 |
| 190007084 | 190001745 | 1.81 | 61.8 | Curative (C) | 2018-11-16 | 2018-11-16 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101167734 |
| 190007087 | 190001746 | 1.78 | 82.2 | Neo-adjuvant (N) | 2018-07-20 | 2018-08-09 | Doxorubicin + Olaratumab | N | N | MITOMYCIN INTRAVESICULAR | 101792663 |
| 190007095 | 190001751 | null | null | null | null | 2017-02-26 | OST Euramos 1 Closed Trial - Ai | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100080212 |
| 190007097 | 190001752 | null | null | null | null | 2020-02-26 | OCTREOTIDE | null | null | EC | 101104763 |
| 190007099 | 190001753 | 1.82 | 56.7 | Palliative (P) | 2017-05-07 | 2017-05-09 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101217179 |
| 190007100 | 190001754 | null | null | null | null | 2020-05-26 | STS Rhabdomyosarcoma RMS 2005 IVAVV | null | null | CAPECITABINE + TEMOZOLOMIDE | 101055991 |
| 190007102 | 190001755 | 1.69 | 112 | Palliative (P) | 2017-06-08 | 2017-06-08 | Oxaliplatin + Modified de Gramont | 02 | N | CARBOPLATIN | 100863813 |
| 190007105 | 190001757 | null | null | null | null | 2019-05-10 | CARBOPLATIN + RT | null | null | CARBOPLATIN | 101384034 |
| 190007109 | 190001758 | 1.72 | 76.3 | Palliative (P) | 2018-06-02 | 2018-06-02 | ECarboX | N | N | PAZOPANIB | 101866525 |
| 190007112 | 190001759 | 1.59 | 79.8 | Curative (C) | 2016-12-07 | 2016-12-07 | Cisplatin + Radiotherapy | 02 | null | CISPLATIN | 101211580 |
| 190007113 | 190001760 | 1.75 | 75 | Curative (C) | 2018-01-16 | 2018-02-11 | Carboplatin + Etoposide IV 3 day | 02 | Y | CARBOPLATIN + ETOPOSIDE | 101195531 |
| 190007127 | 190001764 | 1.68 | 90.3 | Curative (C) | 2017-11-16 | 2017-11-18 | Carboplatin + Etoposide iv&po | null | Y | CARBOPLATIN + ETOPOSIDE | 100789348 |
| 190007132 | 190001766 | 1.8 | 66.7 | Curative (C) | 2016-07-28 | 2016-08-04 | EURAMOS TRIAL | 02 | N | TRIAL | 101421953 |
| 190007136 | 190001767 | null | null | null | null | 2018-04-22 | Cisplatin | null | null | CISPLATIN | 100178389 |
| 190007141 | 190001768 | 1.7 | 59.2 | Palliative (P) | 2016-04-03 | 2016-04-06 | Oxaliplatin + Modified de Gramont | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101036834 |
| 190007148 | 190001771 | null | null | null | null | 2019-10-27 | Cisplatin + Radiotherapy + CISPLATIN | null | null | CISPLATIN | 100562213 |
| 190007151 | 190001774 | null | null | null | null | 2018-12-24 | EW EuroEwing 2012 Arm A VIDE | null | null | CARBOPLATIN | 101632479 |
| 190007156 | 190001775 | null | null | null | null | 2018-09-10 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN + ETOPOSIDE | 101193618 |
| 190007157 | 190001776 | null | null | null | null | 2019-09-19 | null | null | null | CAPECITABINE | 100967327 |
| 190007159 | 190001778 | 1.68 | 59 | null | 2019-03-11 | 2019-03-11 | Cisplatin + Gemcitabine (D 1 & 8) | 01 | null | CISPLATIN + GEMCITABINE | 100187295 |
| 190007163 | 190001781 | null | null | Neo-adjuvant (N) | 2019-05-16 | 2019-05-16 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | CISPLATIN + GEMCITABINE | 101415502 |
| 190007166 | 190001783 | 0 | 17.4 | Palliative (P) | 2017-11-06 | 2017-11-15 | Sunitinib | 02 | N | PACLITAXEL | 100421778 |
| 190007167 | 190001784 | 1.61 | 81 | Palliative (P) | 2017-02-09 | 2017-02-16 | Doxorubicin + Ifosfamide | 02 | N | PEMBROLIZUMAB | 100800789 |
| 190007172 | 190001786 | null | null | null | null | 2017-06-25 | null | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101299822 |
| 190007186 | 190001790 | null | null | null | 2019-10-23 | 2019-11-13 | LANREOTIDE | 02 | null | DOXORUBICIN | 101042313 |
| 190007198 | 190001797 | 1.78 | 100.4 | Palliative (P) | 2018-11-06 | 2018-11-09 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | LUTETIUM-177 | 100482513 |
| 190007201 | 190001799 | null | null | null | null | 2016-06-15 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101212854 |
| 190007216 | 190001804 | 1.73 | 55.4 | Curative (C) | 2017-03-29 | 2017-04-01 | EW EuroEwing 2012 Arm B VDC | 02 | N | METHOTREXATE + VINBLASTINE | 100127293 |
| 190007219 | 190001806 | null | null | Curative (C) | 2016-03-24 | 2016-04-09 | ETOPOSIDE + IFOSFAMIDE | 02 | Y | GEMCARBO | 100016169 |